Specialty Silicone Fabricators to expand manufacturing facility

NewsGuard 100/100 Score

Medical manufacturing is a bright spot in the U.S. economy, as evidenced by Specialty Silicone Fabricators, which is expanding into a new 100,000-square-foot manufacturing facility. The new facility is designed to meet the growing demand for silicone medical device components and support the manufacturing of new medical technologies such as combination products.

U.S.-owned Specialty Silicone Fabricators employs 300 people and has built a worldwide reputation for manufacturing highly specialized silicone medical components. While some medical manufacturing companies have moved to lower-wage countries in an effort to expand, SSF has based its growth strategy on the value of the knowledge, experience, and creativity of its highly skilled employees. That strategy is paying off as a global market increasingly seeks the company out for its proprietary silicone manufacturing capabilities.

This year alone, SSF will provide products and services to over 160 medical device customers in 17 countries, ranging from new startups to the Fortune 20.

The products include components that are used in hundreds of lifesaving devices such as shunts, pacemaker leads, and a device to hold the beating heart during surgery. Silicone membranes produced by SSF are used to grow islet cells that researchers believe may hold the cure for certain types of diabetes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global health boost as new vaccine SKYTyphoid gains WHO prequalification